Frank van Leth

Associate Professor Health Sciences

Limited Benefit of the New Shorter Multidrug-Resistant Tuberculosis Regimen in Europe.


Journal article


C. Lange, R. Duarte, M. Fréchet-Jachym, G. Guenther, L. Guglielmetti, I. Olaru, O. Oliveira, R. Rumetshofer, N. Veziris, F. van Leth
American Journal of Respiratory and Critical Care Medicine, 2016

Semantic Scholar DOI PubMed
Cite

Cite

APA   Click to copy
Lange, C., Duarte, R., Fréchet-Jachym, M., Guenther, G., Guglielmetti, L., Olaru, I., … van Leth, F. (2016). Limited Benefit of the New Shorter Multidrug-Resistant Tuberculosis Regimen in Europe. American Journal of Respiratory and Critical Care Medicine.


Chicago/Turabian   Click to copy
Lange, C., R. Duarte, M. Fréchet-Jachym, G. Guenther, L. Guglielmetti, I. Olaru, O. Oliveira, R. Rumetshofer, N. Veziris, and F. van Leth. “Limited Benefit of the New Shorter Multidrug-Resistant Tuberculosis Regimen in Europe.” American Journal of Respiratory and Critical Care Medicine (2016).


MLA   Click to copy
Lange, C., et al. “Limited Benefit of the New Shorter Multidrug-Resistant Tuberculosis Regimen in Europe.” American Journal of Respiratory and Critical Care Medicine, 2016.


BibTeX   Click to copy

@article{c2016a,
  title = {Limited Benefit of the New Shorter Multidrug-Resistant Tuberculosis Regimen in Europe.},
  year = {2016},
  journal = {American Journal of Respiratory and Critical Care Medicine},
  author = {Lange, C. and Duarte, R. and Fréchet-Jachym, M. and Guenther, G. and Guglielmetti, L. and Olaru, I. and Oliveira, O. and Rumetshofer, R. and Veziris, N. and van Leth, F.}
}


Share

Tools
Translate to